Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
Aln-4324
Obese Or Overweight Healthy Volunteers
Phase I
Recruiting
A Phase 1 Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers
Feb 20, 2025
―
Aln-Agt01 Rvr
Healthy Volunteers
Phase I
Active Not Recruiting
A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers
Oct 29, 2024
―
Aln-6400
Healthy Volunteers
Phase I
Recruiting
A Study to Evaluate ALN-6400 in Adult Healthy Volunteers
Oct 24, 2024
―
Zilebesiran
Mild To Moderate Hypertension
Phase I/II
Completed
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
May 15, 2024
―
Zilebesiran
Hypertension, High Cardiovascular Risk
Phase II
Active Not Recruiting
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)
Feb 15, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alnylam Pharmaceuticals (ALNY) have in its pipeline
ALNY is currently developing the following drugs: Sterile Normal Saline (0.9% Nacl), Nucresiran, Aln-4324, Vutrisiran. These drug candidates are in various stages of clinical development as the company works toward FDA approval.